BioCentury
ARTICLE | Company News

Ingenex other research news

February 27, 1995 8:00 AM UTC

The Menlo Park, Calif., company received a $100,000 Phase I SBIR from the NIH to develop genetic suppressor elements (GSEs) to treat HIV and to identify human genes that may be involved in the disease. ...